FDA approves SC delivery of Takeda’s Entyvio for Crohn’s disease
The regulator has authorised Entyvio as a maintenance drug for individuals with moderately to highly active Crohn's disease…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Apr 24
The regulator has authorised Entyvio as a maintenance drug for individuals with moderately to highly active Crohn's disease…
19 Apr 24
The pharma company is currently recruiting patients in the Phase 2 GenePHIT study to assess the safety and…
18 Apr 24
In both the late-stage trials, the drug reduced the AHI against the placebo and achieved a mean AHI…
18 Apr 24
The results of the final trial showed that Shingrix is effective against shingles with high vaccine efficacy rate…
17 Apr 24
The approval was based on findings from three clinical studies that demonstrated Nulibry's safety and effectiveness in MoCD…
17 Apr 24
According to the results, Imfinzi along with chemotherapy decreased the mortality risk by 26% versus chemotherapy alone at…
17 Apr 24
Vaccine candidate provides broad coverage against the five most common groups of bacteria causing invasive meningococcal disease and…
17 Apr 24
CSafe, an active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, proudly announces the launch of…
17 Apr 24
The 89th edition of the China International Medical Equipment Fair (CMEF) witnessed an impressive turnout of over 200,000 attendees from more…
17 Apr 24
Insightec reaffirms its position at the forefront of the medical technology industry with improved functionality, safety features, and…